Login/Register

Vernalis receives $2m milestone as part of research collaboration

Company News

Vernalis receives $2m milestone as part of research collaboration

Fri, 21 April 2017
Article viewed 26 times
http://stmedia.digitallook.com/web/img/dl/dsc_0009mpp004.jpg
bool(true)
Vernalis receives $2m milestone as part of research collaboration
Vernalis plc Quote more

Price: 18.63

Chg: 0.13

Chg %: 0.68%

Date: 16:35

(ShareCast News) - Shares in Vernalis tumbled on Friday despite the drug developer announcing it had received a $2m milestone under one of its existing research collaborations.
The collaboration was to discover novel small molecules against an undisclosed target using Vernalis' fragment and structure-based drug discovery platform.

Chief executive Ian Garland said: "We are delighted to receive this payment which recognises the success of our research group's work."

Shares in Vernalis were down 13.71% to 21.25p at 0915 BST.